1. Home
  2. ESPR vs GNTY Comparison

ESPR vs GNTY Comparison

Compare ESPR & GNTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ESPR
  • GNTY
  • Stock Information
  • Founded
  • ESPR 2008
  • GNTY 1913
  • Country
  • ESPR United States
  • GNTY United States
  • Employees
  • ESPR N/A
  • GNTY N/A
  • Industry
  • ESPR Biotechnology: Pharmaceutical Preparations
  • GNTY Major Banks
  • Sector
  • ESPR Health Care
  • GNTY Finance
  • Exchange
  • ESPR Nasdaq
  • GNTY Nasdaq
  • Market Cap
  • ESPR 445.6M
  • GNTY 520.5M
  • IPO Year
  • ESPR 2013
  • GNTY 2017
  • Fundamental
  • Price
  • ESPR $2.83
  • GNTY $48.75
  • Analyst Decision
  • ESPR Buy
  • GNTY Buy
  • Analyst Count
  • ESPR 6
  • GNTY 2
  • Target Price
  • ESPR $6.50
  • GNTY $44.50
  • AVG Volume (30 Days)
  • ESPR 6.1M
  • GNTY 41.0K
  • Earning Date
  • ESPR 11-06-2025
  • GNTY 10-20-2025
  • Dividend Yield
  • ESPR N/A
  • GNTY 2.06%
  • EPS Growth
  • ESPR N/A
  • GNTY 38.57
  • EPS
  • ESPR N/A
  • GNTY 3.15
  • Revenue
  • ESPR $268,125,000.00
  • GNTY $127,325,000.00
  • Revenue This Year
  • ESPR $10.59
  • GNTY $10.99
  • Revenue Next Year
  • ESPR N/A
  • GNTY $4.83
  • P/E Ratio
  • ESPR N/A
  • GNTY $15.44
  • Revenue Growth
  • ESPR N/A
  • GNTY 10.12
  • 52 Week Low
  • ESPR $0.69
  • GNTY $32.04
  • 52 Week High
  • ESPR $3.94
  • GNTY $50.50
  • Technical
  • Relative Strength Index (RSI)
  • ESPR 78.99
  • GNTY 57.90
  • Support Level
  • ESPR $2.37
  • GNTY $48.30
  • Resistance Level
  • ESPR $2.73
  • GNTY $49.31
  • Average True Range (ATR)
  • ESPR 0.16
  • GNTY 0.73
  • MACD
  • ESPR 0.02
  • GNTY -0.08
  • Stochastic Oscillator
  • ESPR 99.32
  • GNTY 32.17

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.

About GNTY Guaranty Bancshares Inc.

Guaranty Bancshares Inc is a bank holding company conducting banking activities through its wholly-owned subsidiary. The company provides its customers with a full array of relationship-driven commercial and consumer banking products and services, as well as mortgage, trust, and wealth management products and services that are tailored to meet the needs of small and medium-sized businesses, professionals, and individuals. It also provides other services such as Credit cards, Personal Loans, Business Checking, Treasury Management, and other related services. The company generates its revenue from interest on loans and investments, customer service and loan fees, fees related to the sale of mortgage loans, and trust and wealth management services.

Share on Social Networks: